€245.95, in stock, dispatched from the EU within 24 hours.
Category: Metabolic Research, purity 99%+.
Retatrutide is a synthetic single-molecule triple agonist with activity at the GIP, GLP-1 and glucagon receptors, making it one of the most closely followed next-generation incretin research peptides. It is investigated in the context of energy metabolism, glucose and lipid handling, and receptor-signalling crosstalk in cellular and preclinical models. Researchers use Retatrutide to study how simultaneous activation of three metabolic receptors influences adipose-tissue biology, appetite-regulating pathways and mitochondrial activity. Its multi-receptor profile makes it a reference compound for comparative incretin and metabolic-signalling studies. Third-party tested to 99%+ purity and supplied as a lyophilized powder for laboratory reconstitution. For research purposes only, not for human consumption. Supplied in a pre-filled multi-dose auto-injector pen format for convenient laboratory handling.
For research purposes only. Not for human consumption.